Cargando…

LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1

Triple-negative breast cancer (TNBC) is a highly metastatic breast cancer subtype and due to the lack of hormone receptors and HER2 expression, TNBC has limited therapeutic options with chemotherapy being the primary choice for systemic therapy. LIM Domain Kinase 2 (LIMK2) is a serine/threonine kina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malvi, Parmanand, Janostiak, Radoslav, Chava, Suresh, Manrai, Padmini, Yoon, Esther, Singh, Kamaljeet, Harigopal, Malini, Gupta, Romi, Wajapeyee, Narendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455732/ https://www.ncbi.nlm.nih.gov/pubmed/32859889 http://dx.doi.org/10.1038/s41389-020-00263-1

Ejemplares similares

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma
por: Janostiak, Radoslav, et al.
Publicado: (2019)

Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression
por: Malvi, Parmanand, et al.
Publicado: (2019)

N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production
por: Malvi, Parmanand, et al.
Publicado: (2021)

Transcriptional regulators and alterations that drive melanoma initiation and progression
por: Gupta, Romi, et al.
Publicado: (2020)

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022)

Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth
por: Chava, Suresh, et al.
Publicado: (2022)

HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B
por: Malvi, Parmanand, et al.
Publicado: (2023)

Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018)

PSPH promotes melanoma growth and metastasis by metabolic-deregulation–mediated transcriptional activation of NR4A1
por: Rawat, Vipin, et al.
Publicado: (2021)

Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis
por: Chava, Suresh, et al.
Publicado: (2022)

Dissecting the role of RNA modification regulatory proteins in melanoma
por: Malvi, Parmanand, et al.
Publicado: (2019)

The many faces of SRPK1
por: Bullock, Nicholas, et al.
Publicado: (2017)

CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer
por: Bugide, Suresh, et al.
Publicado: (2023)

Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
por: Gammons, M V, et al.
Publicado: (2014)

LKB1 preserves genome integrity by stimulating BRCA1 expression
por: Gupta, Romi, et al.
Publicado: (2015)

Deletion of Limk1 and Limk2 in mice does not alter cochlear development or auditory function
por: Fang, Qiaojun, et al.
Publicado: (2019)

Data on the expression of SRPK1a in mammals
por: Vlassi, Metaxia, et al.
Publicado: (2019)

Identification of the Mutational Landscape of Gynecological Malignancies
por: Chava, Suresh, et al.
Publicado: (2020)

Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression
por: Chandra, Anshuman, et al.
Publicado: (2020)

Structural Aspects of LIMK Regulation and Pharmacology
por: Chatterjee, Deep, et al.
Publicado: (2022)

Interferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth
por: Gupta, Romi, et al.
Publicado: (2016)

LIMK1 and LIMK2 regulate cortical development through affecting neural progenitor cell proliferation and migration
por: Mao, Rui, et al.
Publicado: (2019)

LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features
por: Villalonga, Elodie, et al.
Publicado: (2023)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway
por: Shi, Weiwei, et al.
Publicado: (2021)

Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
por: Gout, Stephanie, et al.
Publicado: (2012)

Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development
por: Dave, Jaydev, et al.
Publicado: (2023)

Keratinocyte Migration in the Developing Eyelid Requires LIMK2
por: Rice, Dennis S., et al.
Publicado: (2012)

Imbalanced LIMK1 and LIMK2 expression leads to human colorectal cancer progression and metastasis via promoting β-catenin nuclear translocation
por: Zhang, Yue, et al.
Publicado: (2018)

Recruiting a Silent Partner for Activation of the Protein Kinase SRPK1
por: Aubol, Brandon E., et al.
Publicado: (2014)

Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease
por: Bisserier, Malik, et al.
Publicado: (2019)

Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis
por: Chava, Suresh, et al.
Publicado: (2021)

Lessons from LIMK1 enzymology and their impact on inhibitor design
por: Salah, Eidarus, et al.
Publicado: (2019)

Pathogenic fungi neutralize plant‐derived ROS via Srpk1 deacetylation
por: Zhang, Ning, et al.
Publicado: (2023)

A CLINICAL STUDY OF POSITIVE AND NEGATIVE SUBTYPES OF SCHIZOPHRENIA
por: Kota, Suresh K., et al.
Publicado: (1988)

Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies
por: Janostiak, Radoslav, et al.
Publicado: (2022)

ROCK1 and LIMK2 Interact in Spread but Not Blebbing Cancer Cells
por: Shea, Kerry F., et al.
Publicado: (2008)

Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression
por: McConnell, Brice V, et al.
Publicado: (2011)

The conserved kinase SRPK regulates karyosome formation and spindle microtubule assembly in Drosophila oocytes
por: Loh, Benjamin J., et al.
Publicado: (2012)

The crucial role of SRPK1 in IGF-1-induced EMT of human gastric cancer
por: Wang, Hong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sfrfitqll4bg4sru1if0d6o7hf